• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利：CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法，用中文像聊天一样搜索，搜遍4000万医学文献。AI智能推荐，让科研检索更轻松。

立即免费搜索

文件翻译

保留排版，准确专业，支持PDF/Word/PPT等文件格式，支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述，25分钟生成高质量综述，智能提取关键信息，辅助科研写作。

立即免费体验

What oncologists need and require from nuclear medicine.

作者信息

Pantaleo M A, Fanti S, Nannini M, Boschi S, Nanni C, Maleddu A, Rubello D, Biasco G

出版信息

Eur J Nucl Med Mol Imaging. 2008 Oct;35(10):1761-5. doi: 10.1007/s00259-008-0825-y.

DOI:10.1007/s00259-008-0825-y
PMID:18509632
Abstract
摘要

相似文献

1
What oncologists need and require from nuclear medicine.
Eur J Nucl Med Mol Imaging. 2008 Oct;35(10):1761-5. doi: 10.1007/s00259-008-0825-y.
2
[Nuclear medicine meets radiation therapy- the radiooncologist's view].
Nuklearmedizin. 2010;49 Suppl 1:S11-5.
3
[Regional approach in oncology supportive care].[肿瘤支持治疗中的区域方法]
Soins. 2006 Mar(703):52-3.
4
[New challenges in medical oncology. From medical oncology to oncological medicine].[肿瘤内科学的新挑战。从肿瘤内科学到肿瘤医学]
Ann Med Interne (Paris). 2003 May;154(3):131-2.
5
The Day Two Talk: Early Integration of Palliative Care Principles in Pediatric Oncology.第二天的演讲：姑息治疗原则在儿科肿瘤学中的早期整合
J Clin Oncol. 2016 Dec;34(34):4068-4070. doi: 10.1200/JCO.2016.69.3739. Epub 2016 Sep 30.
6
[Nuclear oncology 2000: the end of individualized professionalism].[2000年核肿瘤学：个体化专业精神的终结]
Rev Esp Med Nucl. 2000 Jun;19(3):179-81.
7
A cardio-oncology experience in Italy: results of a Tuscany regional-based survey.意大利的心脏肿瘤学经验：一项基于托斯卡纳地区的调查结果。
J Cardiovasc Med (Hagerstown). 2014 Feb;15(2):135-40. doi: 10.2459/JCM.0b013e328363805b.
8
[The organization of psycho-oncology].[心理肿瘤学的组织架构]
Cancer Radiother. 2002 Nov;6 Suppl 1:214s-218s. doi: 10.1016/s1278-3218(02)00210-x.
9
Tumour boards in geriatric oncology.老年肿瘤肿瘤委员会
Age Ageing. 2018 Mar 1;47(2):168-170. doi: 10.1093/ageing/afx171.
10
The role of oncologists in multidisciplinary cancer teams in the UK: an untapped resource for team leadership?英国多学科癌症团队中肿瘤学家的作用：团队领导的未开发资源？
J Eval Clin Pract. 2011 Dec;17(6):1200-6. doi: 10.1111/j.1365-2753.2010.01507.x. Epub 2010 Jul 27.

引用本文的文献

1
Prognostic significance of changes of tumor epidermal growth factor receptor expression after neoadjuvant chemoradiation in patients with rectal adenocarcinoma.新辅助放化疗后直肠腺癌患者肿瘤表皮生长因子受体表达变化的预后意义。
Strahlenther Onkol. 2012 Sep;188(9):833-8. doi: 10.1007/s00066-012-0160-x. Epub 2012 Aug 1.
2
Evaluation of modified PEG-anilinoquinazoline derivatives as potential agents for EGFR imaging in cancer by small animal PET.通过小动物 PET 评价改良 PEG-苯胺喹唑啉衍生物作为潜在的 EGFR 成像剂在癌症中的应用。
Mol Imaging Biol. 2010 Dec;12(6):616-25. doi: 10.1007/s11307-010-0315-z.

本文引用的文献

1
Application of PET/CT in the development of novel anticancer drugs.正电子发射断层扫描/计算机断层扫描（PET/CT）在新型抗癌药物研发中的应用
Oncologist. 2008 Jan;13(1):25-38. doi: 10.1634/theoncologist.2007-0097.
2
Evaluation of [(18)F]gefitinib as a molecular imaging probe for the assessment of the epidermal growth factor receptor status in malignant tumors.评估[(18)F]吉非替尼作为一种分子成像探针用于评估恶性肿瘤中表皮生长因子受体状态的情况。
Eur J Nucl Med Mol Imaging. 2008 Jun;35(6):1089-99. doi: 10.1007/s00259-007-0636-6. Epub 2008 Feb 1.
3
Conventional and novel PET tracers for imaging in oncology in the era of molecular therapy.
分子治疗时代用于肿瘤成像的传统和新型正电子发射断层显像（PET）示踪剂。
Cancer Treat Rev. 2008 Apr;34(2):103-21. doi: 10.1016/j.ctrv.2007.10.001. Epub 2007 Dec 4.
4
Quantitative justification of the change from 10% to 30% for human epidermal growth factor receptor 2 scoring in the American Society of Clinical Oncology/College of American Pathologists guidelines: tumor heterogeneity in breast cancer and its implications for tissue microarray based assessment of outcome.美国临床肿瘤学会/美国病理学家学会指南中人类表皮生长因子受体2评分从10%变更为30%的定量依据：乳腺癌中的肿瘤异质性及其对基于组织微阵列的预后评估的影响
J Clin Oncol. 2007 Dec 1;25(34):5418-25. doi: 10.1200/JCO.2007.12.8033.
5
Characterizing the cancer genome in lung adenocarcinoma.表征肺腺癌中的癌症基因组。
Nature. 2007 Dec 6;450(7171):893-8. doi: 10.1038/nature06358. Epub 2007 Nov 4.
6
Nuclear factor-kB tumor expression predicts response and survival in irinotecan-refractory metastatic colorectal cancer treated with cetuximab-irinotecan therapy.核因子-κB肿瘤表达可预测接受西妥昔单抗-伊立替康治疗的伊立替康难治性转移性结直肠癌的疗效和生存情况。
J Clin Oncol. 2007 Sep 1;25(25):3930-5. doi: 10.1200/JCO.2007.11.5022.
7
Decoding global gene expression programs in liver cancer by noninvasive imaging.通过非侵入性成像解码肝癌中的全局基因表达程序
Nat Biotechnol. 2007 Jun;25(6):675-80. doi: 10.1038/nbt1306. Epub 2007 May 21.
8
Correlation of computed tomography and positron emission tomography in patients with metastatic gastrointestinal stromal tumor treated at a single institution with imatinib mesylate: proposal of new computed tomography response criteria.在单机构接受甲磺酸伊马替尼治疗的转移性胃肠道间质瘤患者中计算机断层扫描与正电子发射断层扫描的相关性：新的计算机断层扫描反应标准的提议
J Clin Oncol. 2007 May 1;25(13):1753-9. doi: 10.1200/JCO.2006.07.3049.
9
PET detection of epidermal growth factor receptor in colorectal cancer: a real predictor of response to cetuximab treatment?正电子发射断层扫描（PET）检测结直肠癌中表皮生长因子受体：西妥昔单抗治疗反应的真正预测指标？
Eur J Nucl Med Mol Imaging. 2007 Sep;34(9):1510-1. doi: 10.1007/s00259-007-0420-7. Epub 2007 Apr 20.
10
Clinical relevance of KRAS mutation detection in metastatic colorectal cancer treated by Cetuximab plus chemotherapy.西妥昔单抗联合化疗治疗的转移性结直肠癌中KRAS突变检测的临床相关性
Br J Cancer. 2007 Apr 23;96(8):1166-9. doi: 10.1038/sj.bjc.6603685. Epub 2007 Mar 20.